2023 Q1 Form 10-K Financial Statement
#000168316823001974 Filed on March 30, 2023
Income Statement
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | |||
YoY Change | |||
% of Gross Profit | |||
Research & Development | $54.00K | $259.0K | $486.0K |
YoY Change | 12.5% | 184.62% | 38.86% |
% of Gross Profit | |||
Depreciation & Amortization | $1.000K | $1.000K | $4.000K |
YoY Change | 0.0% | -50.0% | -42.86% |
% of Gross Profit | |||
Operating Expenses | $54.00K | $520.0K | $486.0K |
YoY Change | -78.23% | 52.05% | -59.06% |
Operating Profit | -$240.0K | -$1.251M | |
YoY Change | -3.23% | 5.39% | |
Interest Expense | -$94.00K | -$119.0K | -$360.0K |
YoY Change | 22.08% | -232.22% | 54.51% |
% of Operating Profit | |||
Other Income/Expense, Net | |||
YoY Change | |||
Pretax Income | -$334.0K | -$639.0K | -$1.548M |
YoY Change | 10.96% | 153.57% | 9.01% |
Income Tax | $0.00 | ||
% Of Pretax Income | |||
Net Earnings | -$334.0K | -$639.0K | -$1.548M |
YoY Change | 10.96% | 153.57% | 9.01% |
Net Earnings / Revenue | |||
Basic Earnings Per Share | $0.00 | $0.00 | |
Diluted Earnings Per Share | $0.00 | $0.00 | $0.00 |
COMMON SHARES | |||
Basic Shares Outstanding | 382.6M shares | 370.6M shares | 361.8M shares |
Diluted Shares Outstanding | 378.4M shares | 361.8M shares |
Balance Sheet
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $107.0K | $133.0K | $133.0K |
YoY Change | 72.58% | 16.67% | 16.67% |
Cash & Equivalents | $107.0K | $133.0K | |
Short-Term Investments | |||
Other Short-Term Assets | $12.00K | $19.00K | $19.00K |
YoY Change | 20.0% | 35.71% | 35.71% |
Inventory | |||
Prepaid Expenses | $12.00K | $19.00K | |
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $119.0K | $152.0K | $152.0K |
YoY Change | 65.28% | 18.75% | 18.75% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | $5.000K | $6.000K | $6.000K |
YoY Change | -96.53% | -33.33% | -96.05% |
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | $5.000K | $6.000K | $6.000K |
YoY Change | -96.53% | -96.05% | -96.05% |
TOTAL ASSETS | |||
Total Short-Term Assets | $119.0K | $152.0K | $152.0K |
Total Long-Term Assets | $5.000K | $6.000K | $6.000K |
Total Assets | $124.0K | $158.0K | $158.0K |
YoY Change | -42.59% | -43.57% | -43.57% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $2.021M | $1.962M | $2.908M |
YoY Change | 13.22% | 13.67% | 68.48% |
Accrued Expenses | $0.00 | $0.00 | |
YoY Change | -100.0% | -100.0% | |
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $1.912M | $1.940M | $1.940M |
YoY Change | 13.27% | 17.36% | 17.36% |
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $4.909M | $4.848M | $4.848M |
YoY Change | 8.2% | 11.53% | 11.53% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | $0.00 | $0.00 | |
YoY Change | -100.0% | -100.0% | |
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | -100.0% | -100.0% | -100.0% |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $4.909M | $4.848M | $4.848M |
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
Total Liabilities | $4.909M | $4.848M | $4.848M |
YoY Change | 5.91% | 8.87% | 8.87% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$124.5M | -$124.1M | |
YoY Change | 1.26% | ||
Common Stock | $384.5K | $376.1K | |
YoY Change | 5.85% | ||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | -$4.785M | -$4.690M | -$4.690M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $124.0K | $158.0K | $158.0K |
YoY Change | -42.59% | -43.57% | -43.57% |
Cashflow Statement
Concept | 2023 Q1 | 2022 Q4 | 2022 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$334.0K | -$639.0K | -$1.548M |
YoY Change | 10.96% | 153.57% | 9.01% |
Depreciation, Depletion And Amortization | $1.000K | $1.000K | $4.000K |
YoY Change | 0.0% | -50.0% | -42.86% |
Cash From Operating Activities | -$146.0K | -$352.0K | -$923.0K |
YoY Change | 89.61% | 69.23% | 27.84% |
INVESTING ACTIVITIES | |||
Capital Expenditures | $0.00 | $1.000K | |
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | |||
YoY Change | |||
Cash From Investing Activities | $0.00 | -$1.000K | |
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | $0.00 | ||
YoY Change | -100.0% | ||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | $120.0K | 233.0K | $943.0K |
YoY Change | 380.0% | -4.51% | 20.28% |
NET CHANGE | |||
Cash From Operating Activities | -$146.0K | -352.0K | -$923.0K |
Cash From Investing Activities | 0.000 | -$1.000K | |
Cash From Financing Activities | $120.0K | 233.0K | $943.0K |
Net Change In Cash | -$26.00K | -119.0K | $19.00K |
YoY Change | -50.0% | -430.56% | -69.35% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$146.0K | -$352.0K | -$923.0K |
Capital Expenditures | $0.00 | $1.000K | |
Free Cash Flow | -$352.0K | -$924.0K | |
YoY Change | 27.98% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001103795 | |
CY2022 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2022 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2022 | |
CY2022 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
CY2022 | dei |
Document Type
DocumentType
|
10-K | |
CY2022 | dei |
Document Annual Report
DocumentAnnualReport
|
true | |
CY2022 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2022-12-31 | |
CY2022 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2022 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2022 | dei |
Entity File Number
EntityFileNumber
|
0-29185 | |
CY2022 | dei |
Entity Registrant Name
EntityRegistrantName
|
QS ENERGY, INC. | |
CY2022 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
NV | |
CY2022 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
52-2088326 | |
CY2022 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
23902 FM 2978 | |
CY2022 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Tomball | |
CY2022 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
TX | |
CY2022 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
77375 | |
CY2022 | dei |
City Area Code
CityAreaCode
|
(775) | |
CY2022 | dei |
Local Phone Number
LocalPhoneNumber
|
300-7647 | |
CY2022 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
CY2022 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
CY2022 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2022 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2022 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2022 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2022 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2022 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2022Q4 | dei |
Entity Public Float
EntityPublicFloat
|
16914000 | usd |
CY2023Q1 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
382557426 | shares |
CY2022 | dei |
Auditor Firm
AuditorFirmId
|
572 | |
CY2022 | dei |
Auditor Name
AuditorName
|
Weinberg & Company, P.A. | |
CY2022 | dei |
Auditor Location
AuditorLocation
|
Los Angeles, California | |
CY2022Q4 | us-gaap |
Cash
Cash
|
133000 | usd |
CY2021Q4 | us-gaap |
Cash
Cash
|
114000 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
19000 | usd |
CY2021Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
14000 | usd |
CY2022Q4 | us-gaap |
Assets Current
AssetsCurrent
|
152000 | usd |
CY2021Q4 | us-gaap |
Assets Current
AssetsCurrent
|
128000 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
6000 | usd |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
9000 | usd |
CY2022Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
0 | usd |
CY2021Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
143000 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
158000 | usd |
CY2021Q4 | us-gaap |
Assets
Assets
|
280000 | usd |
CY2022Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1962000 | usd |
CY2021Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1726000 | usd |
CY2022Q4 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
946000 | usd |
CY2021Q4 | us-gaap |
Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
930000 | usd |
CY2022Q4 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
1865000 | usd |
CY2021Q4 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
1503000 | usd |
CY2022Q4 | us-gaap |
Other Notes Payable Current
OtherNotesPayableCurrent
|
75000 | usd |
CY2021Q4 | us-gaap |
Other Notes Payable Current
OtherNotesPayableCurrent
|
150000 | usd |
CY2022Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
0 | usd |
CY2021Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
38000 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4848000 | usd |
CY2021Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4347000 | usd |
CY2022Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
0 | usd |
CY2021Q4 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
106000 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
4848000 | usd |
CY2021Q4 | us-gaap |
Liabilities
Liabilities
|
4453000 | usd |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2021Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
500000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
376074096 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
376074096 | shares |
CY2022 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
59000 | usd |
CY2022 | us-gaap |
Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
|
283000 | usd |
CY2021Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
355300222 | shares |
CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
355300222 | shares |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
376075 | usd |
CY2021Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
355301 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
119075925 | usd |
CY2021Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
118065699 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-124142000 | usd |
CY2021Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-122594000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4690000 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4173000 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
158000 | usd |
CY2021Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
280000 | usd |
CY2022 | us-gaap |
Revenues
Revenues
|
0 | usd |
CY2021 | us-gaap |
Revenues
Revenues
|
0 | usd |
CY2022 | us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
765000 | usd |
CY2021 | us-gaap |
Other Cost And Expense Operating
OtherCostAndExpenseOperating
|
837000 | usd |
CY2022 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
486000 | usd |
CY2021 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
350000 | usd |
CY2022 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1251000 | usd |
CY2021 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1187000 | usd |
CY2022 | qsep |
Ppp Loan Debt Forgiveness
PppLoanDebtForgiveness
|
63000 | usd |
CY2021 | qsep |
Ppp Loan Debt Forgiveness
PppLoanDebtForgiveness
|
0 | usd |
CY2022 | us-gaap |
Interest And Debt Expense
InterestAndDebtExpense
|
360000 | usd |
CY2021 | us-gaap |
Interest And Debt Expense
InterestAndDebtExpense
|
233000 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1548000 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1420000 | usd |
CY2022 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.00 | |
CY2022 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.00 | |
CY2021 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.00 | |
CY2021 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.00 | |
CY2022 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
361790243 | shares |
CY2022 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
361790243 | shares |
CY2021 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
336041213 | shares |
CY2021 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
336041213 | shares |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-3507000 | usd |
CY2021 | qsep |
Cumulative Effect Adjustment For Adoption Of Asu202006 See Note4
CumulativeEffectAdjustmentForAdoptionOfAsu202006SeeNote4
|
-30000 | usd |
CY2021 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
128000 | usd |
CY2021 | us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
261000 | usd |
CY2021 | us-gaap |
Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
|
290000 | usd |
CY2021 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
40000 | usd |
CY2021 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
20000 | usd |
CY2021 | qsep |
Fair Value Of Options And Warrants Issued For Services
FairValueOfOptionsAndWarrantsIssuedForServices
|
45000 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1420000 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4173000 | usd |
CY2022 | qsep |
Common Stock Issued On Exercise Of Warrants
CommonStockIssuedOnExerciseOfWarrants
|
542000 | usd |
CY2022 | qsep |
Fair Value Of Options And Warrants Issued For Services
FairValueOfOptionsAndWarrantsIssuedForServices
|
127000 | usd |
CY2022 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
20000 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1548000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4690000 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1548000 | usd |
CY2021 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1420000 | usd |
CY2022 | qsep |
Fair Value Of Common Stock Issued For Services
FairValueOfCommonStockIssuedForServices
|
0 | usd |
CY2021 | qsep |
Fair Value Of Common Stock Issued For Services
FairValueOfCommonStockIssuedForServices
|
40000 | usd |
CY2022 | qsep |
Fair Value Of Common Stock Issued As Compensation
FairValueOfCommonStockIssuedAsCompensation
|
0 | usd |
CY2021 | qsep |
Fair Value Of Common Stock Issued As Compensation
FairValueOfCommonStockIssuedAsCompensation
|
20000 | usd |
CY2022 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
127000 | usd |
CY2021 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
45000 | usd |
CY2022 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
149000 | usd |
CY2021 | us-gaap |
Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
|
59000 | usd |
CY2022 | qsep |
Accrued Interest Expense
AccruedInterestExpense
|
162000 | usd |
CY2021 | qsep |
Accrued Interest Expense
AccruedInterestExpense
|
124000 | usd |
CY2022 | qsep |
Decrease In Operating Lease Right Of Use Asset
DecreaseInOperatingLeaseRightOfUseAsset
|
143000 | usd |
CY2021 | qsep |
Decrease In Operating Lease Right Of Use Asset
DecreaseInOperatingLeaseRightOfUseAsset
|
22000 | usd |
CY2022 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
4000 | usd |
CY2021 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
7000 | usd |
CY2022 | qsep |
Gain On Partial Forgiveness Of Ppp Notes Payable
GainOnPartialForgivenessOfPppNotesPayable
|
63000 | usd |
CY2021 | qsep |
Gain On Partial Forgiveness Of Ppp Notes Payable
GainOnPartialForgivenessOfPppNotesPayable
|
-0 | usd |
CY2022 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
5000 | usd |
CY2021 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-32000 | usd |
CY2022 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
16000 | usd |
CY2021 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
230000 | usd |
CY2022 | us-gaap |
Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
|
236000 | usd |
CY2021 | us-gaap |
Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
|
235000 | usd |
CY2022 | us-gaap |
Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
|
0 | usd |
CY2021 | us-gaap |
Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
|
-95000 | usd |
CY2022 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-144000 | usd |
CY2021 | us-gaap |
Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
|
-21000 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-923000 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-722000 | usd |
CY2022 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
1000 | usd |
CY2021 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
-0 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-1000 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | usd |
CY2022 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | usd |
CY2021 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
128000 | usd |
CY2022 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
393000 | usd |
CY2021 | us-gaap |
Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
|
658000 | usd |
CY2022 | us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
562000 | usd |
CY2021 | us-gaap |
Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
|
0 | usd |
CY2022 | qsep |
Principal Payment On Ppp Loan Payable
PrincipalPaymentOnPppLoanPayable
|
12000 | usd |
CY2021 | qsep |
Principal Payment On Ppp Loan Payable
PrincipalPaymentOnPppLoanPayable
|
2000 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
943000 | usd |
CY2021 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
784000 | usd |
CY2022 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
19000 | usd |
CY2021 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
62000 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
114000 | usd |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
52000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
133000 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
114000 | usd |
CY2022 | us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | usd |
CY2021 | us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | usd |
CY2022 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
1600 | usd |
CY2021 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
1600 | usd |
CY2022 | qsep |
Adjustment For Adoption Of Asu202006
AdjustmentForAdoptionOfAsu202006
|
0 | usd |
CY2021 | qsep |
Adjustment For Adoption Of Asu202006
AdjustmentForAdoptionOfAsu202006
|
30000 | usd |
CY2022 | qsep |
Recording Of Operating Lease Right Of Use Asset And Liability
RecordingOfOperatingLeaseRightOfUseAssetAndLiability
|
0 | usd |
CY2021 | qsep |
Recording Of Operating Lease Right Of Use Asset And Liability
RecordingOfOperatingLeaseRightOfUseAssetAndLiability
|
165000 | usd |
CY2022 | qsep |
Conversion Of Convertible Notes To Common Stock Net
ConversionOfConvertibleNotesToCommonStockNet
|
59000 | usd |
CY2021 | qsep |
Conversion Of Convertible Notes To Common Stock Net
ConversionOfConvertibleNotesToCommonStockNet
|
261000 | usd |
CY2022 | qsep |
Value Of Warrants And Beneficial Conversion Feature Associated With Issued Convertible Notes
ValueOfWarrantsAndBeneficialConversionFeatureAssociatedWithIssuedConvertibleNotes
|
283000 | usd |
CY2021 | qsep |
Value Of Warrants And Beneficial Conversion Feature Associated With Issued Convertible Notes
ValueOfWarrantsAndBeneficialConversionFeatureAssociatedWithIssuedConvertibleNotes
|
290000 | usd |
CY2022 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1548000 | usd |
CY2022 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-923000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-4690000 | usd |
CY2022Q4 | us-gaap |
Notes Payable
NotesPayable
|
1730000 | usd |
CY2022Q4 | us-gaap |
Cash
Cash
|
133000 | usd |
CY2021Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
101000 | usd |
CY2022Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
96000 | usd |
CY2021Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
92000 | usd |
CY2022 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p id="xdx_845_eus-gaap--UseOfEstimates_zPND7nuwo4Ba" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><b><span style="text-decoration: underline"><span id="xdx_869_zPDWuyQsf8f1">Use of Estimates</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Significant estimates include those related to assumptions used in impairment analysis for property and equipment, assumption used in valuing the issuance of convertible notes and the corresponding debt discount, assumptions used in valuing equity instruments issued for services, and valuation allowance for deferred tax assets, among others. Actual results could differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><b> </b></p> | |
CY2022 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
0 | usd |
CY2021 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
0 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
6000 | usd |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
9000 | usd |
CY2022 | us-gaap |
Depreciation
Depreciation
|
4000 | usd |
CY2021 | us-gaap |
Depreciation
Depreciation
|
7000 | usd |
CY2022 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
486000 | usd |
CY2021 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
350000 | usd |
CY2022Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
102000 | usd |
CY2022Q4 | us-gaap |
Convertible Debt Current
ConvertibleDebtCurrent
|
1393000 | usd |
CY2021Q4 | us-gaap |
Convertible Debt Current
ConvertibleDebtCurrent
|
1137000 | usd |
CY2022Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
612000 | usd |
CY2021Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
452000 | usd |
CY2022Q4 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
2005000 | usd |
CY2021Q4 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
1589000 | usd |
CY2022Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
140000 | usd |
CY2021Q4 | us-gaap |
Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
|
86000 | usd |
CY2022Q4 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
1865000 | usd |
CY2021Q4 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
1503000 | usd |
CY2021 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
59000 | usd |
CY2022 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
149000 | usd |
CY2021Q1 | qsep |
Decrease In Retained Earnings Accumulated Deficit
DecreaseInRetainedEarningsAccumulatedDeficit
|
30000 | usd |
CY2022 | qsep |
Gain On Forgiveness Of Ppp Loan
GainOnForgivenessOfPppLoan
|
63000 | usd |
CY2022 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
486000 | usd |
CY2021 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
350000 | usd |
CY2022 | us-gaap |
Revenues
Revenues
|
0 | usd |
CY2021 | us-gaap |
Revenues
Revenues
|
0 | usd |
CY2022 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-167000 | usd |
CY2021 | us-gaap |
Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
|
-150000 | usd |
CY2022 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
167000 | usd |
CY2021 | us-gaap |
Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
|
150000 | usd |
CY2022 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd |
CY2021 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
13124000 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
13008000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Liabilities Deferred Expense
DeferredTaxLiabilitiesDeferredExpense
|
27000 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Liabilities Deferred Expense
DeferredTaxLiabilitiesDeferredExpense
|
9000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
35000 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
|
18000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
13132000 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
13017000 | usd |
CY2022Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | usd |
CY2021Q4 | us-gaap |
Deferred Tax Assets Net
DeferredTaxAssetsNet
|
0 | usd |
CY2022Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
62000000 | usd |
CY2022 | us-gaap |
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
|
0.21 | pure |
CY2022Q4 | qsep |
Accrued Expenses Related Parties
AccruedExpensesRelatedParties
|
6000 | usd |
CY2021Q4 | qsep |
Accrued Expenses Related Parties
AccruedExpensesRelatedParties
|
0 | usd |
CY2022Q4 | us-gaap |
Other Commitment Due In Next Twelve Months
OtherCommitmentDueInNextTwelveMonths
|
384500 | usd |
CY2022Q4 | us-gaap |
Other Commitment Due In Second Year
OtherCommitmentDueInSecondYear
|
187500 | usd |
CY2022Q4 | us-gaap |
Other Commitment Due In Third Year
OtherCommitmentDueInThirdYear
|
187500 | usd |
CY2022Q4 | us-gaap |
Other Commitment Due In Fourth Year
OtherCommitmentDueInFourthYear
|
187500 | usd |
CY2022Q4 | us-gaap |
Other Commitment Due In Fifth Year
OtherCommitmentDueInFifthYear
|
187500 | usd |
CY2022Q4 | us-gaap |
Other Commitment
OtherCommitment
|
1134500 | usd |
CY2022Q4 | us-gaap |
Supplemental Unemployment Benefits Severance Benefits
SupplementalUnemploymentBenefitsSeveranceBenefits
|
197000 | usd |